Eisai Enters into License Agreement for the Development and Distribution of Fibroblast Growth Factor (FGF) Receptor Selective Tyrosine Kinase Inhibitor Tasurgratinib in Greater China Region (Mainland China, Hong Kong, Macau, and Taiwan) with SciClone
Chifeng Jilong Gold Mining, the Largest Non-State Owned Gold Producer in China, Announces Details of Proposed Listing on the Main Board of HKEX
